These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 35973171)
1. A Combined Baveno VII and Spleen Stiffness Algorithm to Improve the Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease. Dajti E; Ravaioli F; Marasco G; Alemanni LV; Colecchia L; Ferrarese A; Cusumano C; Gemini S; Vestito A; Renzulli M; Golfieri R; Festi D; Colecchia A Am J Gastroenterol; 2022 Nov; 117(11):1825-1833. PubMed ID: 35973171 [TBL] [Abstract][Full Text] [Related]
2. Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta. Jachs M; Sandmann L; Hartl L; Tergast T; Schwarz M; Bauer DJM; Balcar L; Ehrenbauer A; Hofer BS; Cornberg M; Lenzen H; Deterding K; Trauner M; Mandorfer M; Wedemeyer H; Reiberger T; Maasoumy B J Hepatol; 2024 Aug; 81(2):248-257. PubMed ID: 38479612 [TBL] [Abstract][Full Text] [Related]
3. Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis. Dajti E; Ravaioli F; Zykus R; Rautou PE; Elkrief L; Grgurevic I; Stefanescu H; Hirooka M; Fraquelli M; Rosselli M; Chang PEJ; Piscaglia F; Reiberger T; Llop E; Mueller S; Marasco G; Berzigotti A; Colli A; Festi D; Colecchia A; Lancet Gastroenterol Hepatol; 2023 Sep; 8(9):816-828. PubMed ID: 37478880 [TBL] [Abstract][Full Text] [Related]
4. High accuracy of spleen stiffness measurement in diagnosing clinically significant portal hypertension in metabolic-associated fatty liver disease. Odriozola A; Puente Á; Cuadrado A; Iruzubieta P; Arias-Loste MT; Redondo C; Rivas C; Fábrega E; Crespo J; Fortea JI Liver Int; 2023 Jul; 43(7):1446-1457. PubMed ID: 36912787 [TBL] [Abstract][Full Text] [Related]
5. Validation of Baveno VII criteria for clinically significant portal hypertension by two-dimensional shear wave elastography. He R; Liu C; Grgurevic I; Guo Y; Xu H; Liu J; Liu Y; Wang X; Shi H; Madir A; Podrug K; Zhu Y; Hua Y; Wang K; Wen J; Su M; Zhang Q; Li J; Qi X Hepatol Int; 2024 Jun; 18(3):1020-1028. PubMed ID: 38740698 [TBL] [Abstract][Full Text] [Related]
6. The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal Hypertension. Jachs M; Hartl L; Simbrunner B; Bauer D; Paternostro R; Scheiner B; Balcar L; Semmler G; Stättermayer AF; Pinter M; Quehenberger P; Trauner M; Reiberger T; Mandorfer M Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1854-1863.e10. PubMed ID: 36244661 [TBL] [Abstract][Full Text] [Related]
7. THE ROLE OF ELASTOGRAPHY IN CLINICALLY SIGNIFICANT PORTAL HYPERTENSION. Mattos AA; Mattos AZ; Sartori GDP; Both GT; Tovo CV Arq Gastroenterol; 2023; 60(4):525-535. PubMed ID: 38018555 [TBL] [Abstract][Full Text] [Related]
8. Validation of non-invasive diagnosis of CSPH in patients with compensated advanced chronic liver disease according to Baveno VII. Song BG; Goh MJ; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Paik SW; Sinn DH Liver Int; 2023 Sep; 43(9):1966-1974. PubMed ID: 37288716 [TBL] [Abstract][Full Text] [Related]
9. Spleen Stiffness-Based Algorithms Are Superior to Baveno VI Criteria to Rule Out Varices Needing Treatment in Patients With Advanced Chronic Liver Disease. Vanderschueren E; Armandi A; Kwanten W; Cassiman D; Francque S; Schattenberg JM; Laleman W Am J Gastroenterol; 2024 Aug; 119(8):1515-1524. PubMed ID: 38502095 [TBL] [Abstract][Full Text] [Related]
10. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease. Colecchia A; Ravaioli F; Marasco G; Colli A; Dajti E; Di Biase AR; Bacchi Reggiani ML; Berzigotti A; Pinzani M; Festi D J Hepatol; 2018 Aug; 69(2):308-317. PubMed ID: 29729368 [TBL] [Abstract][Full Text] [Related]
11. Exploring algorithms to select candidates for non-selective beta-blockers in cirrhosis: A post hoc analysis of the PREDESCI trial. Dajti E; Villanueva C; Berzigotti A; Brujats A; Albillos A; Genescà J; García-Pagán JC; Colecchia A; Bosch J; ; J Hepatol; 2024 Sep; ():. PubMed ID: 39303875 [TBL] [Abstract][Full Text] [Related]
12. ABC: a novel algorithm to stratify decompensation risk in patients with compensated advanced chronic liver disease (CHESS2108): an international, multicenter cohort study. Liu C; Li J; Wong YJ; Xie Q; Hirooka M; Enomoto H; Kim TH; Hanafy AS; He R; Koizumi Y; Hiasa Y; Nishimura T; Iijima H; Jung YK; Yim HJ; Ma J; Zeng QL; Sarin SK; Qi X Hepatol Int; 2022 Oct; 16(5):1105-1115. PubMed ID: 35606627 [TBL] [Abstract][Full Text] [Related]
14. Baveno VII algorithm outperformed other models in ruling out high-risk varices in individuals with HBV-related cirrhosis. Zhang X; Song J; Zhang Y; Wen B; Dai L; Xi R; Wu Q; Li Y; Luo X; Lan X; He Q; Luo W; Lai Q; Ji Y; Zhou L; Qi T; Liu M; Zhou F; Wen W; Li H; Liu Z; Chen Y; Zhu Y; Li J; Huang J; Cheng X; Tu M; Hou J; Wang H; Chen J J Hepatol; 2023 Mar; 78(3):574-583. PubMed ID: 36356684 [TBL] [Abstract][Full Text] [Related]
15. Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease. Pons M; Augustin S; Scheiner B; Guillaume M; Rosselli M; Rodrigues SG; Stefanescu H; Ma MM; Mandorfer M; Mergeay-Fabre M; Procopet B; Schwabl P; Ferlitsch A; Semmler G; Berzigotti A; Tsochatzis E; Bureau C; Reiberger T; Bosch J; Abraldes JG; Genescà J Am J Gastroenterol; 2021 Apr; 116(4):723-732. PubMed ID: 33982942 [TBL] [Abstract][Full Text] [Related]
16. Enhancing liver cirrhosis varices and CSPH risk prediction with spleen stiffness measurement using 100-Hz probe. Yoo JJ; Maeng SA; Chang Y; Lee SH; Jeong SW; Jang JY; Cheon GJ; Kim YS; Kim HS; Kim SG Sci Rep; 2024 Jun; 14(1):13674. PubMed ID: 38871788 [TBL] [Abstract][Full Text] [Related]
17. Simple blood tests to diagnose compensated advanced chronic liver disease and stratify the risk of clinically significant portal hypertension. Semmler G; Hartl L; Mendoza YP; Simbrunner B; Jachs M; Balcar L; Schwarz M; Hofer BS; Fritz L; Schedlbauer A; Stopfer K; Neumayer D; Maurer J; Szymanski R; Meyer EL; Scheiner B; Quehenberger P; Trauner M; Aigner E; Berzigotti A; Reiberger T; Mandorfer M Hepatology; 2024 Oct; 80(4):887-900. PubMed ID: 38447034 [TBL] [Abstract][Full Text] [Related]